Successful tocilizumab treatment for rapidly progressive interstitial lung disease with anti-MDA5-positive juvenile dermatomyositis: a case report and literature review
BackgroundCurrently, no established integrated treatment regimen exists for anti-melanoma differentiation-associated gene 5 (anti-MDA5)-positive juvenile dermatomyositis (JDM) complicated by rapidly progressive interstitial lung disease (RP-ILD). We present a case of refractory anti-MDA5-positive JD...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2024-11-01
|
| Seri Bilgileri: | Frontiers in Pediatrics |
| Konular: | |
| Online Erişim: | https://www.frontiersin.org/articles/10.3389/fped.2024.1497168/full |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|